Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”

Abstract EN

In the article titled “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease” [1], reference [28] was incorrectly added as follows:[28]“Y.

Chen, S.-C.

Xu, and R.-D.

Duan, ‘Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells,’ Lipids in Health and Disease, vol.

14, no.

1, article 130, 2015.”It should be replaced with the following reference:[28]“Chen Y, et al.

Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.

Mol Cancer Ther, 14:1, 259-67, 2015.”